Corcept Therapeutics Affirms FY2026 Sales Guidance of $1.100B-$1.200B vs $1.146B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Corcept Therapeutics (NASDAQ:CORT) affirms FY2026 sales outlook from $1.100 billion-$1.200 billion to $1.100 billion-$1.200 billion vs $1.146 billion estimate.
Corcept Therapeutics (NASDAQ:CORT) affirms FY2026 sales outlook from $1.100 billion-$1.200 billion to $1.100 billion-$1.200 billion vs $1.146 billion estimate.